Chargement en cours...
Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion
The identification of driver mutations in epidermal growth factor receptor, anaplastic lymphoma kinase, the BRAF and ROS1 genes and subsequent successful clinical development of kinase inhibitors not only significantly improves clinical outcomes but also facilitates the discovery of other novel driv...
Enregistré dans:
| Publié dans: | Ther Adv Med Oncol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984433/ https://ncbi.nlm.nih.gov/pubmed/32047535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919895756 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|